PLx Pharma
About:
PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets.
Website: http://www.plxpharma.com
Top Investors: Armentum Partners, Aurus, UT Horizon Fund, Integra Ventures, Emerald Private Equity Fund
Description:
PLx Pharma is a pharmaceutical company that develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine; and PL1100/1200 Ibuprofen, which are oral drug products containing a molecular complex of ibuprofen and phosphatidylcholine.
$89.6M
$1M to $10M
Houston, Texas, United States
2002-01-01
ron.zimmerman(AT)plxpharma.com
Lenard M. Lichtenberger, Ronald R. Zimmerman
11-50
2021-03-03
Public
© 2025 bioDAO.ai